Onconova Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.33
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.21
|
-0.26
|
-0.05
|
-23.81%
|
|
2022-06-30
|
-0.20
|
-0.19
|
0.01
|
5.00%
|
|
2022-03-31
|
-0.19
|
-0.20
|
-0.01
|
-5.26%
|
|
2021-12-31
|
-0.27
|
-0.15
|
0.12
|
44.44%
|
|
2021-09-30
|
-0.33
|
-0.22
|
0.11
|
33.33%
|
|
2021-06-30
|
-0.28
|
-0.27
|
0.01
|
3.57%
|
|
2021-03-31
|
-0.45
|
-0.30
|
0.15
|
33.33%
|
|
2020-12-31
|
-0.52
|
-0.45
|
0.07
|
13.46%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.65
|
|
2021-12-31
|
-0.94
|
|
2020-12-31
|
-1.95
|
|
2019-12-31
|
-27.53
|
|
2018-12-31
|
-8.46
|
|
2017-12-31
|
-42.30
|
|
2016-12-31
|
-18.31
|
|
2015-12-31
|
-10.60
|
|
2014-12-31
|
-259.10
|
|
2013-12-31
|
-12024.23
|